MABION S.A.

MAB
End-of-day quote. End-of-day quote  - 10/20
71PLN -7.79%
Prev.77.0000
Open74.8000
High75.0000
Low67.2000
Volume691 523
Latest news
09/20
09/16
05/20
05/14
Chart MABION S.A.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBullish
Resistance85,485,493,5
Spread/Res.-17%-17%-24%
Spread/Supp.0,85%63%70%
Support70,443,641,7
Financials
Sales 2021 11,3 M 2,86 M 2,86 M
Net income 2021 -59,0 M -15,0 M -15,0 M
Net Debt 2021 20,8 M 5,29 M 5,29 M
P/E ratio 2021 -19,3x
Yield 2021 -
Capitalization 1 147 M 291 M 292 M
EV / Sales 2021 104x
EV / Sales 2022 4,50x
Nbr of Employees 213
Free-Float 63,7%
Company
Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
No events available

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Last Close Price 71,00 PLN
Average target price 68,50 PLN
Spread / Average Target -3,52%